Improvements in Hemoglobin and Cognitive Function from Opera: A Real-World Study of Pegcetacoplan Treatment in US Adults with Paroxysmal Nocturnal Hemoglobinuria

被引：1

作者：

Fishman, Jesse ^{[1
]}

Min, Jinny ^{[1
]}

Arnett, Lily ^{[2
]}

Shenoy, Apeksha ^{[2
]}

机构：

[1] Apellis Pharmaceut, Waltham, MA USA

[2] Boston Strateg Partners Inc, Boston, MA USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-189167

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] IDENTIFICATION AND DESCRIPTION OF REAL-WORLD DATA SOURCES FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): A REVIEW OF LITERATURE
Lavudiya, S.
Agrawal, R.
Rovira, G.
Studer, R.
VALUE IN HEALTH, 2020, 23 : S715 - S715
[32] Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population
Cheng, Wendy Y.
Sarda, Sujata P.
Mody-Patel, Nikita
Krishnan, Sangeeta
Yenikomshian, Mihran
Mahendran, Malena
Lejeune, Dominique
Yu, Louise H.
Duh, Mei Sheng
ADVANCES IN THERAPY, 2021, 38 (08) : 4461 - 4479
[33] Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population
Wendy Y. Cheng
Sujata P. Sarda
Nikita Mody-Patel
Sangeeta Krishnan
Mihran Yenikomshian
Malena Mahendran
Dominique Lejeune
Louise H. Yu
Mei Sheng Duh
Advances in Therapy, 2021, 38 : 4461 - 4479
[34] Benefits and Limitations of Long-Term Eculizumab Treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH): Real-World Data from Large Cohort Study in Russia
Kulagin, Aleksandr
Klimova, Olesya
Rudakova, Tatiana
Golubovskaya, Irina
Ivanova, Maria
Smirnova, Anna
Lapina, Alexandra
Bykova, Tatiana
Babenko, Elena
Popova, Marina
Dobronravov, Vladimir
Afanasyev, Boris
BLOOD, 2018, 132
[35] Evaluation of the Long-Term Safety and Efficacy of Pegcetacoplan Treatment for Paroxysmal Nocturnal Hemoglobinuria Patients: An Extension Study
Hoffman, Kate
Machaidze, Zurab
Yeh, Michael
Weitz, Ilene C.
BLOOD, 2021, 138
[36] Real-World Clinical Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Eculizumab or Ravulizumab in the US: A Retrospective Claims Database Analysis
Tantravahi, Srinivas
Latremouille-Viau, Dominick
Desai, Raj
Lee, Soyon
Paulose, Jincy
Geevarghese, Anumaxine
Guerin, Anne
Seshasayee, Shravanthi
Chanpura, Mohin
Yen, Glorian
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S599 - S599
[37] Treatment with Pegcetacoplan leads to clinically relevant improvements in quality of life and fatigue in patients with paroxysmal nocturnal hemoglobinuria: results from two phase 3 studies
Hoechsmann, B.
Kubal, T.
Mulherin, B. P.
Yeh, M.
Al-Adhami, M.
Savage, J.
Dingli, D.
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 234 - 234
[38] PREVALENCE, REAL-WORLD HEALTHCARE RESOURCE UTILIZATION, AND COSTS OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN THE US: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS
Tantravahi, S.
Latremouille-Viau, D.
Desai, R.
Lee, S.
Paulose, J.
Geevarghese, A.
Guerin, A.
Seshasayee, S.
Tabatabaeepour, N.
Chanpura, M.
Yen, G.
VALUE IN HEALTH, 2024, 27 (06) : S140 - S140
[39] PHYSICIAN VERSUS PATIENT PERCEPTION OF DISEASE, SYMPTOMATIC BURDEN AND PREFERENCE FOR TREATMENT ADMINISTRATION IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): RESULTS FROM A REAL-WORLD STUDY
Han, Bing
Balp, Maria-Magdalena
Snellman, Josefin
Wiyani, Anggie
O'Neill, Caitriona
Mellor, Jennifer
Earl, Lucy
Taylor, Yasmin
Munir, Talha
BONE MARROW TRANSPLANTATION, 2024, 59 : 774 - 776
[40] PATIENT AND PHYSICIAN SATISFACTION OF TREATMENT WITH ECULIZUMAB OR RAVULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM A REAL-WORLD DISEASE-SPECIFIC PROGRAMME
Fureder, W.
Mellor, J.
Earl, L.
Wang, A.
Patel, Y.
Myren, K. J.
Nagalla, S.
VALUE IN HEALTH, 2023, 26 (06) : S347 - S347

← 1 2 3 4 5 →